PTPI - Petros Analyst Forecast Prices

Corporate company logo of Petros Pharmaceuticals Inc (PTPI)

Petros Pharmaceuticals (PTPI) is implementing eco-friendly packaging solutions and reducing transportation emissions in compliance with ESG standards. The business relies on the confidential delivery of men's health products via online channels, which minimizes costs. This daily price chart reflects a level of 0.00. Growth prospects are linked to portfolio maturity and the ambition to transition core medications to over-the-counter status to capture new market niches.

Petros Pharmaceuticals, Inc. (PTPI) - Analyst Consensus Forecast from 07/04/2022 to 06/28/2025
Flagship merchandise of Petros Pharma

For investors in Petros Pharmaceuticals (PTPI), this indicator serves as a tool to verify market expectations amid geopolitical risks that constrain drug sales and component logistics. By analyzing the current consensus target price, which represents the weighted average of forecasts from leading banks, one can determine the degree of the asset's undervaluation relative to the business's fundamental value under conditions of external volatility.

Competitors of Petros Pharmaceuticals

HLN: Forecast Levels Chart|Kenvue - Consensus Target|Analyst Forecast Prices VRNA (Verona Pharma PLC)|MENS - Price Target Chart|Forecast Levels Chart LGND|AMRX: Analyst Consensus Forecast|PRGO - Analyst Median Target|Price Target Chart Alvotech SA|Liquidia Corp - Forecast Levels Chart|Analyst Consensus Forecast GLPG|ANIP (ANI Pharmaceuticals Corp) - Fair Value Consensus|Analyst Consensus Forecast MNKD (MannKind Corporation)|Analyst Consensus Forecast amphastar.com AMPH|PCRX - Price Target Chart|Fair Value Consensus SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Price Target Chart|Consensus Target Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast Tectonic|Consensus Target TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Fair Value Consensus|Price Target Chart Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Average Forecast Price|EXOZ: Consensus Target|Oramed Pharmaceuticals - Analyst Forecast Prices|ENTX: Analyst Consensus Forecast|MindWalk Holdings, Inc. - Fair Value Consensus|ABVC (ABVC BioPharma Inc) - Analyst Consensus Forecast|Average Forecast Price Cumberland Corp CPIX|Price Target Chart Quantum BioPharma Ltd (QNTM)|FGEN (fibrogen.com) - Fair Value Consensus|Price Target Chart Telomir Pharmaceuticals, Inc. TELO|RANI (Rani Therapeutics Holdings) - Forecast Levels Chart|Synergy CHC Corporation - Analyst Consensus Forecast|Average Forecast Price Rallybio Corporation|LEXX (lexariabioscience.com) - Consensus Target|PULM: Analyst Forecast Prices|Price Target Chart Pheton Holdings Limited|APM: Fair Value Consensus|Price Target Chart Lyra Therapeutics, Inc (LYRA)|IBO - Average Forecast Price|Price Target Chart TNF Pharmaceuticals, Inc. TNFA|Analyst Median Target cbdMD Inc. (YCBD)|PRFX: Consensus Target|Fair Value Consensus CYTO (Altamira Therapeutics)|Lipella (LIPO) - Price Target Chart|Forecast Levels Chart OPTN (OptiNose Corp)|PIRS (Pieris Pharmaceuticals) - Analyst Consensus Forecast|PROC: Fair Value Consensus|Analyst Consensus Forecast QLI|Analyst Consensus Forecast Acelyrin Inc. (SLRN)|Price Target Chart TFF Pharma TFFP